Ron Christopher Charles - 01 Oct 2023 Form 3 Insider Report for Chemours Co (CC)

Role
Senior Vice President, People
Signature
/s/ Nicole Perez Lengel, Attorney-in-Fact
Issuer symbol
CC
Transactions as of
01 Oct 2023
Net transactions value
$0
Form type
3
Filing time
03 Oct 2023, 19:53:53 UTC
Next filing
06 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CC Common Stock 17,509 01 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CC Stock Option (Right to Buy) 01 Oct 2023 Common Stock 5,045 $34.84 Direct F2
holding CC Stock Option (Right to Buy) 01 Oct 2023 Common Stock 6,066 $25.98 Direct F3
holding CC Stock Option (Right to Buy) 01 Oct 2023 Common Stock 6,646 $24.01 Direct F4
holding CC Stock Option (Right to Buy) 01 Oct 2023 Common Stock 2,798 $48.53 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes stock units and dividend equivalent units.
F2 Option award was granted on March 1, 2023 with vesting in three equal annual installments beginning March 1, 2024.
F3 Option award was granted on March 1, 2022 with vesting in three equal annual installments beginning March 1, 2023.
F4 Option award was granted on March 1, 2021 with vesting in three equal annual installments beginning March 1, 2022.
F5 Options are fully vested.

Remarks:

Power of Attorney attached as Exhibit 24.